InvestorsObserver
×
News Home

Sunshine Biopharma, Inc. (SBFM) Down 4.34% in Premarket Trading

Tuesday, April 19, 2022 06:53 AM | InvestorsObserver Analysts

Mentioned in this article

Sunshine Biopharma, Inc. (SBFM) Down 4.34% in Premarket Trading

Sunshine Biopharma, Inc. (SBFM) is down Tuesday morning, with the stock losing -4.34% in pre-market trading to 3.31. SBFM's short-term technical score of 13 indicates that the stock has traded less bullishly over the last month than 87% of stocks on the market. In the Drug Manufacturers - Specialty & Generic industry, which ranks 136 out of 146 industries, SBFM ranks higher than 25% of stocks. Sunshine Biopharma, Inc. has risen 6.46% over the past month, closing at $2.70 on March 22. During this period of time, the stock fell as low as $2.26 and as high as $9.87.

Overall Score - 26
SBFM has an Overall Score of 26. Find out what this means to you and get the rest of the rankings on SBFM!
Sunshine Biopharma, Inc. has a Long-Term Technical rank of 64. This means that trading over the last 200 trading days has placed the company in the upper half of stocks with 36% of the market scoring higher. In the Drug Manufacturers - Specialty & Generic industry which is number 122 by this metric, SBFM ranks better than 78% of stocks.

Important Dates for Investors in SBFM:

-We do not have a set earnings date for Sunshine Biopharma, Inc. at this time. -We do not have a set dividend date for Sunshine Biopharma, Inc. at this time. Click Here To Get The Full Report on Sunshine Biopharma, Inc. (SBFM)

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App